Literature DB >> 31391517

Encapsulation of Isoniazid-conjugated Phthalocyanine-In-Cyclodextrin-In-Liposomes Using Heating Method.

Christian Isalomboto Nkanga1, Rui Werner Maçedo Krause2.   

Abstract

Liposomes are reputed colloidal vehicles that hold the promise for targeted delivery of anti-tubercular drugs (ATBDs) to alveolar macrophages that host Mycobacterium tuberculosis. However, the costly status of liposome technology, particularly due to the use of special manufacture equipment and expensive lipid materials, may preclude wider developments of therapeutic liposomes. In this study, we report efficient encapsulation of a complex system, consisting of isoniazid-hydrazone-phthalocyanine conjugate (Pc-INH) in gamma-cyclodextrin (γ-CD), in liposomes using crude soybean lecithin by means of a simple organic solvent-free method, heating method (HM). Inclusion complexation was performed in solution and solid-state, and evaluated using UV-Vis, magnetic circular dichroism, 1H NMR, diffusion ordered spectroscopy and FT-IR. The HM-liposomes afforded good encapsulation efficiency (71%) for such a large Pc-INH/γ-CD complex (PCD) system. The stability and properties of the PCD-HM-liposomes look encouraging; with particle size 240 nm and Zeta potential -57 mV that remained unchanged upon storage at 4 °C for 5 weeks. The release study performed in different pH media revealed controlled release profiles that went up to 100% at pH 4.4, from about 40% at pH 7.4. This makes PCD-liposomes a promising system for site-specific ATBD delivery, and a good example of simple liposomal encapsulation of large hydrophobic compounds.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31391517      PMCID: PMC6685989          DOI: 10.1038/s41598-019-47991-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  7 in total

Review 1.  A Comprehensive Review on Novel Liposomal Methodologies, Commercial Formulations, Clinical Trials and Patents.

Authors:  Veera Venkata Satya Naga Lakshmi Andra; S V N Pammi; Lakshmi Venkata Krishna Priya Bhatraju; Lakshmi Kalyani Ruddaraju
Journal:  Bionanoscience       Date:  2022-01-26

Review 2.  Liposomal-Based Formulations: A Path from Basic Research to Temozolomide Delivery Inside Glioblastoma Tissue.

Authors:  Roxana-Maria Amarandi; Alina Ibanescu; Eugen Carasevici; Luminita Marin; Brindusa Dragoi
Journal:  Pharmaceutics       Date:  2022-01-27       Impact factor: 6.321

Review 3.  Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis.

Authors:  Luis Ángel Ibarra-Sánchez; Ana Gámez-Méndez; Manuel Martínez-Ruiz; Erik Francisco Nájera-Martínez; Brando Alan Morales-Flores; Elda M Melchor-Martínez; Juan Eduardo Sosa-Hernández; Roberto Parra-Saldívar; Hafiz M N Iqbal
Journal:  J Drug Deliv Sci Technol       Date:  2022-03-05       Impact factor: 3.981

Review 4.  Current Advances in Specialised Niosomal Drug Delivery: Manufacture, Characterization and Drug Delivery Applications.

Authors:  Bwalya A Witika; Kokoette E Bassey; Patrick H Demana; Xavier Siwe-Noundou; Madan S Poka
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

5.  Ultrasound-Triggered Release of 5-Fluorouracil from Soy Lecithin Echogenic Liposomes.

Authors:  Charles Izuchukwu Ezekiel; Alain Murhimalika Bapolisi; Roderick Bryan Walker; Rui Werner Maçedo Krause
Journal:  Pharmaceutics       Date:  2021-06-01       Impact factor: 6.321

6.  Synthesis and Characterization of pH-Sensitive Inulin Conjugate of Isoniazid for Monocyte-Targeted Delivery.

Authors:  Franklin Afinjuomo; Thomas G Barclay; Ankit Parikh; Rosa Chung; Yunmei Song; Gayathri Nagalingam; Jamie Triccas; Lixin Wang; Liang Liu; John D Hayball; Nikolai Petrovsky; Sanjay Garg
Journal:  Pharmaceutics       Date:  2019-10-28       Impact factor: 6.321

Review 7.  Application of Lipid-Based Nanocarriers for Antitubercular Drug Delivery: A Review.

Authors:  Aristote B Buya; Bwalya A Witika; Alain M Bapolisi; Chiluba Mwila; Grady K Mukubwa; Patrick B Memvanga; Pedzisai A Makoni; Christian I Nkanga
Journal:  Pharmaceutics       Date:  2021-11-30       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.